Images-on-Call adds new serverImages-on-Call has released Teleradiology Server (TS), which allows clinicians to view images from their home or office. With TS, physicians can dial into the server with a special version of the company's
Images-on-Call has released Teleradiology Server (TS), which allows clinicians to view images from their home or office. With TS, physicians can dial into the server with a special version of the company's ViewStation software and look at a patient's list of images. Images can then be selected for transmission to the clinician's computer, according to the Dallas-based firm.
The first TS was installed in the second quarter at Southeast Georgia Regional Medical Center in Brunswick, GA.
In other technology news, Images-on-Call has installed nearly 100 of its DICOM gateways since the product's introduction in 1997, said Bob Maher, sales manager. Sixty of these gateways are the company's DG1 model, which enables technologists to send images to a teleradiology network. Full, 12-bit windowing and leveling of images is possible at the remote site, Maher said.
Images-on-Call also offers DG2, which allows users to move images from a remote location or from a non-DICOM device into a DICOM network. Offerings in the works include DG-P, a system that will allow customers to print to DICOM-connected film printers, Maher said.
Study: AI Boosts Ultrasound AUC for Predicting Thyroid Malignancy Risk by 34 Percent Over TI-RADS
February 17th 2025In a study involving assessment of over 1,000 thyroid nodules, researchers found the machine learning model led to substantial increases in sensitivity and specificity for estimating the risk of thyroid malignancy over traditional TI-RADS and guidelines from the American Thyroid Association.
Can CT-Based AI Provide Automated Detection of Colorectal Cancer?
February 14th 2025For the assessment of contrast-enhanced abdominopelvic CT exams, an artificial intelligence model demonstrated equivalent or better sensitivity than radiologist readers, and greater than 90 percent specificity for the diagnosis of colorectal cancer.
Emerging PET/CT Agent Shows Promise in Detecting PCa Recurrence in Patients with Low PSA Levels
February 13th 202518F-DCFPyL facilitated detection of recurrent prostate cancer in 51 percent of patients with PSA levels ranging between 0.2 to 0.5 ng/ml, according to new research presented at the American Society of Clinical Oncology Genitourinary Cancers (ASCO-GU) Symposium.